Evaluation of the Prognostic Role of Centromere 17 Gain and HER2/topoisomerase II Alpha Gene Status and Protein Expression in Patients With Breast Cancer Treated With Anthracycline-Containing Adjuvant Chemotherapy: Pooled Analysis of Two Hellenic Cooperative Oncology Group (HeCOG) Phase III Trials

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-13-163
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Long-Term Prognostic and Predictive Factors in 107 Stage II/III Breast Cancer Patients Treated With Anthracycline-Based Neoadjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
1997English

P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2019English

Comparison of Immunohistochemistry and Fluorescence in Situ Hybridization for the Analysis of Her2/Neu and Topoisomerase Ii-Alpha Status in Human Breast Cancer

Turk Patoloji Dergisi
Forensic MedicinePathology
2010English

Pathogenic Mutations and Overall Survival in 3,084 Patients With Cancer: The Hellenic Cooperative Oncology Group Precision Medicine Initiative

Oncotarget
Oncology
2019English

Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials

PLoS ONE
Multidisciplinary
2016English

Safety of Ipragliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers Treated With Neoadjuvant Chemotherapy

Targeted Oncology
Cancer ResearchOncologyPharmacology
2018English

Second-Line Pazopanib in Patients With Relapsed and Refractory Small-Cell Lung Cancer: A Multicentre Phase II Study of the Hellenic Oncology Research Group

British Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy